Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on precision psychiatry. It develops biomarker-guided drug candidates for major depressive disorder, bipolar depression, treatment-resistant depression, schizophrenia, and other mental health conditions using its proprietary Precision Psychiatry Platform.

Relationship details are part of the Pro plan.